Case-control, family based and screening for DNA sequence variation in the dopamine transporter gene polymorphism DAT 1 in alcohol dependence;Badania asocjacyjne, badania rodzin i sekwencjonowanie DNA polimorfizmu genu transportera dopaminy DAT 1 w zespole zależności alkoholowej

Psychiatria Polska

Volumn 42, Issue 3, 2008, Pages 443-452

  Grzywacz, Anna ^a,b   Samochowiec, Jerzy ^a  

^a Katedra I Klinika Psychiatrii Pomorskiej AM W Szczecinie   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Alcoholism; Gene DAT 1; Polimorphism

Indexed keywords

DOPAMINE TRANSPORTER; DOPAMINE TRANSPORTER 1; UNCLASSIFIED DRUG;

ALCOHOLISM; ALLELE; ARTICLE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CONTROL GROUP; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SCREENING; DNA SEQUENCE; FAMILY; FATHER; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTHER; OUTCOME ASSESSMENT; PATHOGENESIS; VARIABLE NUMBER OF TANDEM REPEAT; VOLUNTEER;

ADULT; AGED; ALCOHOL DRINKING; ALCOHOLISM; BASE SEQUENCE; CASE-CONTROL STUDIES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 66649092322     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Devor EJ, Cloninger CR. Genetics of alcoholism. Ann. Rev. Genet. 1989; 23: 19-36.
2. Sacchetti P, Brownschidle LA, Granneman JG, Bannon MJ. Characterization of the 5′-flanking region of the human dopamine transporter gene. Brain Res. Mol. Brain Res. 1999; 10, 74: 167-169.
3. Grunhage F, Schulze TG, Muller DJ, Lanczik M, Franzek E, Albus M, Borrmann-Hassenbach M, Knapp M, Cichon S, Maier W, Rietschel M, Propping P, Nothen MM. Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT 1). Mol. Psychiatry 2000; 5: 275-282.
4. Miller GM, Madras BK. Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol. Psychiatry 2002; 7: 44-55.
5. Harper M. Biochemia. Warszawa: PZWL; 1990.
6. Vandenbergh DJ, Thompson MD, Cook EH, Bendahhou E, Nguyen T, Krasowski MD, Zarrabian D, Comings D, Sellers EM, Tyndale RF, George SR, O'Dowd BF, Uhl GR. Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations. Mol. Psychiatry 2000; 5: 283-292.
7. Haeussler J, Haeusler J, Striebel AM, Assum G, Vogel W, Furneaux H, Krone W. Tumor antigen HuR binds specifically to one of five protein-binding segments in the 3′-untranslated region of the neurofibromin messenger RNA. Biochem. Biophys. Res. Comm. 2000; 27, 267: 726-732.
8. Mill J, Asherson P, Browes C, D'Souza U, Craig I. Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RTPCR. Am. J. Med. Genet. 2002; 114: 975-979.
9. Morino H, Kawarai T, Izumi Y, Kazuta T, Oda M, Komure O, Udaka F, Kameyama M, Nakamura S, Kawakami H. A single nucleotide polymorphism of dopamine transporter gene is associated with Parkinson's disease. Ann. Neurol. 2000; 47: 528-531.
10. Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A, Rommelspacher H, Schmidt LG. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol. Psychiatry 1997; 41: 299-304.
11. Miller GM, De La Garza R 2nd, Novak MA, Madras BK. Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders. Mol. Psychiatry 2001; 6: 50-58.
12. Rubie C, Schmidt F, Knapp M, Sprandel J, Wiegand C, Meyer J, Jungkunz G, Riederer P, Stöber G. The human dopamine transporter gene: the 5′-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample. Neurosc. Lett. 2001; 297: 125-128.
13. Segman RH, Cooper-Kazaz R, Macciardi F, Goltser T, Halfon Y, Dobroborski T, Shalev AY. Association between the dopamine transporter gene and posttraumatic stress disorder. Mol. Psychiatry 2002; 7: 903-907.
14. Ueno S, Nakamura M, Mikami M, Kondoh K, Ishiguro H, Arinami T, Komiyama T, Mitsushio H, Sano A, Tanabe H. Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism. Mol. Psychiatry 1999; 4: 552-557.
15. Wernicke C, Samochowiec J, Schmidt LG, Winterer G, Smolka M, Kucharska-Mazur J, Horodnicki J, Gallinat J, Rommelspacher H. Polymorphisms in the N-methyl-D-aspartate receptor 1 and 2B subunits are associated with alcoholism-related traits. Biol. Psychiatry 2003; 54: 922-928.
16. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacol. 2000; 22: 133-139.
17. Schmidt LG, Harms H, Kuhn S, Rommelspacher H, Sander T. Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am. J. Psychiatry 1998; 155: 474-478.
18. Chen WJ, Chen CH, Huang J, Hsu YP, Seow SV, Chen CC, Cheng AT. Genetic polymorphisms of the promoter region of dopamine D2 receptor and dopamine transporter genes and alcoholism among four aboriginal groups and Han Chinese in Taiwan. Psychiatr. Genet. 2001; 11: 187-195.
19. Hauser J, Szczepankiewicz A, Dymitrzak-Wȩglarz M, Skibińska M, Słopień A, Leszczyńska-Rodziewicz A, Czerski P. Badanie polimorfizmu genu DAT w zaburzeniach dwubiegunowych z współ wystȩpuja̧cym uzależnieniem od alkoholu. Alkohol. Narkom. 2007; 20: 167-178.
20. Samochowiec J, Kucharska-Mazur J, Grzywacz A, Jabłoński M, Rommelspacher H, Samochowiec A, Sznabowicz M, Horodnicki J, Sagan L, Pełka-Wysiecka J. Family-based and case control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alkohol dependence. Neurosc. Lett. 2006; 410: 1-5.